Telomere shortening is an early somatic DNA alteration in human prostate tumorigenesis

Cancer Research

Volumn 62, Issue 22, 2002, Pages 6405-6409

  Meeker, Alan K ^a   Hicks, Jessica L ^a   Platz, Elizabeth A ^a,b   March, Gerrun E ^a   De Marzo, Angelo M ^a   Delannoy, Michael J ^a  

^a JOHNS HOPKINS UNIVERSITY SCHOOL OF MEDICINE   (United States)

^b JOHNS HOPKINS BLOOMBERG SCHOOL OF PUBLIC HEALTH   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ADULT; AGED; ARTICLE; CANCER INVASION; CARCINOGENESIS; CHROMOSOMAL PARAMETERS; CHROMOSOME BREAKAGE; CHROMOSOME STRUCTURE; CLINICAL ARTICLE; CONTROLLED STUDY; DNA DAMAGE; HUMAN; HUMAN CELL; HUMAN TISSUE; IN VITRO STUDY; MALE; MALIGNANT TRANSFORMATION; PATHOGENESIS; PRIORITY JOURNAL; PROSTATE ADENOCARCINOMA; PROSTATE CANCER; PROSTATE EPITHELIUM; SOMATIC CELL GENETICS; TELOMERE;

ADENOCARCINOMA; AGED; HUMANS; IN SITU HYBRIDIZATION, FLUORESCENCE; MALE; MIDDLE AGED; NEOPLASM STAGING; PROSTATIC INTRAEPITHELIAL NEOPLASIA; PROSTATIC NEOPLASMS; TELOMERE;

EID: 0037112522     PISSN: 00085472     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (56)

1. Knudson, A, G. Genetics of human cancer. Annu. Rev. Genet., 20: 231-251, 1986
2. Fearon, E. R., and Vogelstein B. A genetic model for colorectal tumorigenesis. Cell. 61: 759-767, 1990
3. Loeb, L. A. Mutator phenotype may be required for multistage carcinogenesis. Cancer Res., 51: 3075-3079, 1991
4. O’Shaughnessy, J. A., Kelloff, G. J., Gordon, G. B., Dannenberg, A. J., Hong, W. K., Fabian, C. J., Sigman, C. C., Bertagnolli, M. M., Stratton, S. P., Lam, S., Nelson, W. G., Meyskens, F. L., Alberts D. S., Follen, M., Rustgi, A. K., Papadimitrakopoulou, V., Scardino, P. T., Gazdar, A. F., Wattenberg, L. W., Sporn, M. B., Sakr, W. A., Lippman, S. M., and Von Hoff, D. D. Treatment and prevention of intraepithelial neoplasia: An important target for accelerated new agent development. Clin. Cancer Res., 8: 314-346, 2002
5. Shih, I. M., Zhou, W., Goodman, S. N., Lengauer, C., Kinzler, K. W., and Vogelstein, B. Evidence that genetic instability occurs at an early stage of colorectal tumorigenesis. Cancer Res., 61: 818-822, 2001
6. Qian, J., Jenkins, R. B., and Bostwick, D. G. Genetic and chromosomal alterations in prostatic intraepithelial neoplasia and carcinoma detected by fluorescence in situ hybridization. Eur. Urol., 35: 479-483, 1999
7. Al-Maghrabi, J., Vorobyova, L., Chapman, W., Jewett, M., Zielenska, M., and Squire, J. A. p53 alteration and chromosomal instability in prostatic high-grade intraepithelial neoplasia and concurrent carcinoma: Analysis by immunohistochemistry interphase in situ hybridization, and sequencing on laser-captured microdissected specimens. Mod. Pathol., 14: 1252-1262, 2001
8. Lengauer, C., Kinzler, K. W., and Vogelstein, B. Genetic instabilities in human cancers. Nature (Lond.), 396: 643-649, 1998
9. Schmutte, C., and Fishel, R. Genomic instability: First step to carcinogenesis. Anticancer Res. 19: 4665-4696, 1999
10. Eshleman, J. R., and Markowitz, S. D. Microsatellite instability in inherited and sporadic neoplasms. Curr. Opin. Oncol., 7: 83-89, 1995
11. Mittelamn, F. Catalog of Chromosome Aberrations in Cancer, 6 Edition. New York: Alan R. Liss, 1998
12. Sandberg, A. A., Chromosomes in human neoplasia. Curr. Probl. Cancer. 8: 1-52, 1983
13. Hartwell, L. H., and Kastan, M. B. Cell cycle control and cancer. Science (Wash. DC), 266: 1821-1828, 1994
14. Jallepalli, P. V., and Lengauer, C. Chromosome segregation and cancer: Cutting through the mystery. Nature Rev. Cancer, 1: 109-117, 2001
15. McClintock, B. The stability of broken ends of chromosomes in Zea mays. Genetics, 26: 234-282, 1941
16. Blackburn, E. H. Telomeres. Trends Biochem. Sci., 16: 378-381, 1991
17. Olovnikov, A. M. Principle of marginotomy in template synthesis of polynucleotides. Dokl. Akad. Nauk., 201: 1496-1499, 1971
18. Smogorzewska, A., van Steensel, B., Bianchi, A., Oelmann, S., Schaefer, M. R., Schnapp, G., and de Lange, T. Control of human telomere length by TRF1 and TRF2. Mol. Cell. Biol. 20: 1659-1668, 2000
19. Bohr, V. A., and Anson, R. M. DNA damage, mutation and fine structure DNA repair in aging. Mutat. Res., 338: 25-34, 1995
20. von Zglinicki, T., Pilger, R., and Sitte, N. Accumulation of single-strand breaks is the major cause of telomere shortening in human fibroblasts. Free Radic. Biol. Med., 28: 64-74, 2000
21. Greider, C. W., and Blackburn, E. H. Identification of a specific telomere terminal transferase activity in tetrahymena extracts. Cell, 43: 405-413, 1985
22. Shay, J. W., Wright, W. E., and Werbin, H. Defining the molecular mechanisms of human cell immortalization, Biochim. Biophys. Acta, 1072: 1-7, 1991
23. Harley, C. B., Kim, N. W., Prowse, K. R., Weinrich, S. L., Hirsch, K. S., West, M. D., Bacchetti, S., Hirte, H. W., Counter, C. M., Greider, C. W., and et al. Telomerase, cell immortality, and cancer. Cold Spring Harbor Symp. Quant. Biol., 59: 307-315, 1994
24. Counter, C., Avilion, A., LeFeuvre, C., Stewart, N., Greider, C., Harley, C., and Bacchetti, S. Telomere shortening associated with chromosome instability is arrested in immortal cells which express telomerase activity. EMBO J., 11: 1921-1929, 1992
25. Lundblad, V., and Szostak, J. W. A mutant with a defect in telomere elongation leads to senescence in yeast. Cell. 57: 633-643, 1989
26. Blasco, M. A., Lee, H. W., Hande, M. P., Samper, E., Lansdorp, P. M., DePinho, R. A., and Greider, C. W. Telomere shortening and tumor formation by mouse cells lacking telomeres RNA. Cell, 91: 25-34, 1997
27. Hastie, N. D., and Allshire, R. C. Human telomeres: Fusion and interstitial sites. Trends Genet., 5: 326-331, 1989
28. von Zglinicki, T. Are the ends of chromosomes the beginning of tumor genesis? On the role of telomeres in cancer development. Fortschr. Med., 114: 12-14, 1996
29. Artandi, S. E., and DePinho, R. A. A critical role for telomeres in suppressing and facilitating carcinogenesis. Curr. Opin. Genet. Dev., 10: 39-46, 2000
30. Artandi, S. E., Chang, S., Lee, S. L., Alson, S., Gottlieb, G. J., Chin, L., and DePinho, R. A. Telomere dysfunction promotes non-reciprocal translocations and epithelial cancers in mice. Nature (Lond.), 406: 641-645, 2000
31. Hastie, N., Dempster, M., Dunlop, M., Thompson, A., Green, D., and Alshire, R. Telomere reduction in human colorectal carcinoma and with ageing. Nature (Lond.), 346: 866-868, 1990
32. Furugori, E., Hirayama, R., Nakamura, K. I., Kammori, M., Esaki, Y., and Takubo, K. Telomere shortening in gastric carcinoma with aging despite telomerase activation. J. Cancer Res. Clin. Oncol., 126: 481-485, 2000
33. Mehle, C., Ljungberg, B., and Roos, G. Telomere shortening in renal cell carcinoma. Cancer Res., 54: 236-241, 1994
34. Takagi, S., Kinouchi, Y., Hiwatashi, N., Chida, M., Nagashima, F., Takahashi, S., Negoro, K., Shimosegawa, T., and Toyota, T. Telomere shortening and the clinicopathologic characteristics of human colorectal carcinomas. Cancer (Phila.), 86: 1431-1436, 1999
35. Sommerfeld, H. J., Meeker, A. K., Piatyszek, M. A., Bova, G. S., Shay, J. W., and Coffey, D. S. Telomerase activity: A prevalent marker of malignant human prostate tissue. Cancer Res., 56: 218-222, 1996
36. Saunders, W. S., Shuster, M., Huang, X., Gharaibeh, B., Enyenihi, A. H., Petersen, I., and Gollin, S. M. Chromosomal instability and cytoskeletal defects in oral cancer cells. Proc. Natl. Acad. Sci, USA. 97: 303-308, 2000
37. Gisselsson, D., Pettersson, L., Hoglund, M., Heidenblad, M., Gorunova, L., Wiegant, J., Mertens, F., Dal Cin, P., Mitelman, F., and Mandahl, N. Chromosomal breakage-fusion-bridge events cause genetic intratumor heterogeneity. Proc. Natl. Acad. Sci. USA, 97: 5357-5362, 2000
38. Rudolph, K. L., Millard, M., Bosenberg, M. W., and DePinho, R. A. Telomere dysfunction and evolution of intestinal carcinoma in mice and humans. Nat. Genet., 28: 155-159, 2001
39. Engelhardt, M., Albanell, J., Drullinsky, P., Han, W., Guillem, J., Scher, H. I., Reuter, V., and Moore, M. A. Relative contribution of normal and neoplastic cells determines telomerase activity and telomere length in primary cancers of the prostate, colon, and sarcoma. Clin. Cancer Res., 3: 1849-1857, 1997
40. Meeker, A. K., Gage, W. R., Hicks, J. L., Simon, I., Coffman, J. R., Platz, E. A., March, G. E., and De Marzo, A. M. Telomere length assessment in human archival tissues: Combined telomere fluorescence in situ hybridization and immunostaining. Am. J. Pathol., 160: 1259-1268, 2002
41. Henderson, S., Allsopp, R., Spector, D., Wang, S. S., and Harley, C. In situ analysis of changes in telomere size during replicative aging and cell transformation. J. Cell Biol., 134: 1-12, 1996
42. Harley, C. B. Telomeres and aging: Fact, fancy, and the future. J. NIH Res., 7: 64-68, 1995
43. Nagele, R. G., Velasco, A. Q., Anderson, W. J., McMahon, D. J., Thomson, Z., Fazekas, J., Wind, K., and Lee, H. Telomere associations in interphase nuclei: Possible role in maintenance of interphase chromosome topology. J. Cell Sci., 114: 377-388, 2001
44. Wang, N., Pan, Y., Heiden, T., and Tribukait, B. Fluorescence image cytometry for measurement of nuclear DNA content in surgical pathology. Cytometry, 22: 323-329, 1995
45. Cowden, R. R., and Curtis, S. K. Microfluorometric investigations of chromatin structure. I. Evaluation of nine DNA-specific fluorochromes as probes of chromatin organization. Histochemistry, 72: 11-23, 1981
46. De Marzo, A. M., Putzi, M. J., and Nelson, W. G. New concepts in the pathology of prostatic epithelial carcinogenesis. Urology, 57: 103-114, 2001
47. Reya, T., Morrison, S. J., Clarke, M. F., and Weissman, I. L. Stem cells, cancer, and cancer stem cells. Nature (Lond.) 414: 105-111, 2001
48. Verhagen, A. P., Ramaekers, F. C., Aalders, T. W., Schaafsma, H. E., Debruyne, F. M., and Schalken, J. A. Colocalization of basal and luminal cell-type cytokeratins in human prostate cancer. Cancer Res., 52: 6182-6187, 1992
49. De Marzo, A. M., Marchi, V. L., Epstein, J. I., and Nelson, W. G. Proliferative inflammatory atrophy of the prostate: Implications for prostatic carcinogenesis. Am. J. Pathol., 155: 1985-1992, 1999
50. Lee, W. H., Morton, R. A., Epstein, J. I., Brooks, J. D., Campbell, P. A., Bova, G. S., Hsieh, W. S., Isaacs, W. B., and Nelson, W. G. Cytidine methylation of regulatory sequences near the pi-class glutathione S-transferase gene accompanies human prostatic carcinogenesis, Proc. Natl. Acad. Sci. USA, 91: 11733-7, 1994
51. Brooks, J. D., Weinstein, M., Lin, X., Sun, Y., Pin, S. S., Bova, G. S., Epstein, J. I., Isaacs, W. B., and Nelson, W. G. CG island methylation changes near the GSTP1 gene in prostatic intraepithelial neoplasia. Cancer Epidemiol. Biomark. Prev., 7: 531-536, 1998
52. Lin, X., Tascilar, M., Lee, W. H., Vles, W. J., Lee, B. H., Veeraswamy, R., Asgari, K., Freije, D., van Rees, B., Gage, W. R., Bova, G. S., Isaacs, W. B., Brooks, J. D., DeWeese, T. L., De Marzo, A. M., and Nelson, W. G. GSTP1 CpG island hypermethylation is responsible for the absence of GSTP1 expression in human prostate cancer cells. Am. J. Pathol., 159: 1815-1826, 2001
53. Koeneman, K. S., Pan, C. X., Jin, J. K., Pyle, J. M., Flanigan, R. C., Shankey, T. V., and Diaz, M. O. Telomerase activity, telomere length, and DNA ploidy in prostatic intraepithelial neoplasia (PIN). J. Urol., 160: 1533-1539, 1998
54. McNeal, J. E., Haillot, O., and Yemoto, C. Cell proliferation in dysplasia of the prostate: Analysis by PCNA immunostaining. Prostate, 27: 258-268, 1995
55. Bonkhoff, H., Stein, U., and Remberger, K. The proliferative function of basal cells in the normal and hyperplastic human prostate. Prostate, 24: 114-118, 1994
56. van Heek, N. T., Meeker, A. K. Kern, S. E., Yeo, C. J., Lillemoe, K. D., Cameron, J. L., Offerhaus, G. J. A., Hicks, J. L., Wilentz, R. E., Goggins, M. G., De Marzo, A. M., Hruban, R. H., and Maitra, A. Telomere shortening is nearly universal in pancreatic intraepithelial neoplasia. Am. J. Pathol., in press, 2002